Literature DB >> 19694710

Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?

Stacy Loeb1, Jonathan I Epstein, Elizabeth B Humphreys, Patrick C Walsh.   

Abstract

OBJECTIVE: To determine the relationship between perineural invasion (PNI) on prostate biopsy and radical prostatectomy (RP) outcomes in a contemporary RP series, as there is conflicting evidence on the prognostic significance of PNI in prostate needle biopsy specimens. PATIENTS AND METHODS: From 2002 to 2007, 1256 men had RP by one surgeon. Multivariable logistic regression and Cox proportional hazards models were used to examine the relationship of PNI with pathological tumour features and biochemical progression, respectively, after adjusting for prostate-specific antigen level, clinical stage and biopsy Gleason score. Additional Cox models were used to examine the relationship between nerve-sparing and biochemical progression among men with PNI.
RESULTS: PNI was found in 188 (15%) patients, and was significantly associated with aggressive pathology and biochemical progression. On multivariate analysis, PNI was significantly associated with extraprostatic extension and seminal vesicle invasion (P < 0.001). Biochemical progression occurred in 10.5% of patients with PNI, vs 3.5% of those without PNI (unadjusted hazard ratio 3.12, 95% confidence interval 1.77-5.52, P < 0.001). However, PNI was not a significant independent predictor of biochemical progression on multivariate analysis. Finally, nerve-sparing did not adversely affect biochemical progression even among men with PNI.
CONCLUSION: PNI is an independent risk factor for aggressive pathology features and a non-independent risk factor for biochemical progression after RP. However, bilateral nerve-sparing surgery did not compromise the oncological outcomes for patients with PNI on biopsy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694710      PMCID: PMC3353268          DOI: 10.1111/j.1464-410X.2009.08845.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

2.  The prostatic perineural space and its relation to tumor spread: an ultrastructural study.

Authors:  M O Hassan; J Maksem
Journal:  Am J Surg Pathol       Date:  1980-04       Impact factor: 6.394

3.  Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate.

Authors:  S I Bastacky; P C Walsh; J I Epstein
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

4.  Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy.

Authors:  Kiaran J O'Malley; Charles R Pound; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2002-01       Impact factor: 2.649

5.  Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy.

Authors:  G F Holmes; P C Walsh; C R Pound; J I Epstein
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

6.  Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy.

Authors:  S R Bonin; A L Hanlon; W R Lee; B Movsas; T I al-Saleem; G E Hanks
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

7.  Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?

Authors:  A de la Taille; M A Rubin; E Bagiella; C A Olsson; R Buttyan; T Burchardt; C Knight; K M O'Toole; A E Katz
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

8.  The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.

Authors:  Matthew R Cooperberg; David J Pasta; Eric P Elkin; Mark S Litwin; David M Latini; Janeen Du Chane; Peter R Carroll
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

9.  Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.

Authors:  Toyonori Tsuzuki; David J Hernandez; Hakan Aydin; Bruce Trock; Patrick C Walsh; Jonathan I Epstein
Journal:  J Urol       Date:  2005-02       Impact factor: 7.450

10.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

View more
  13 in total

1.  Prostate biopsy perineural invasion is not independently associated with positive surgical margins following radical retropubic prostatectomy.

Authors:  Benjamin T Ristau; Jeffrey J Tomaszewski; Yi-Fan Chen; Marnie Bertolet; Elen Woldemichael; Joel B Nelson
Journal:  World J Urol       Date:  2014-11-01       Impact factor: 4.226

2.  Perineural invasion is an independent predictor of biochemical recurrence of prostate cancer after local treatment: a meta-analysis.

Authors:  Yang Meng; Yan-Biao Liao; Peng Xu; Wu-Ran Wei; Jia Wang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Perineural Invasion and Risk of Lethal Prostate Cancer.

Authors:  Piotr Zareba; Richard Flavin; Masis Isikbay; Jennifer R Rider; Travis A Gerke; Stephen Finn; Andreas Pettersson; Francesca Giunchi; Robert H Unger; Alex M Tinianow; Swen-Olof Andersson; Ove Andrén; Katja Fall; Michelangelo Fiorentino; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01-06       Impact factor: 4.254

4.  Perineural Invasion Is an Independent Pathologic Indicator of Recurrence in Vulvar Squamous Cell Carcinoma.

Authors:  Emily R Holthoff; Susanne K Jeffus; Ashita Gehlot; Rebecca Stone; Stephen W Erickson; Thomas Kelly; Charles M Quick; Steven R Post
Journal:  Am J Surg Pathol       Date:  2015-08       Impact factor: 6.394

Review 5.  Tumour innervation and neurosignalling in prostate cancer.

Authors:  Brayden March; Sam Faulkner; Phillip Jobling; Allison Steigler; Alison Blatt; Jim Denham; Hubert Hondermarck
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

6.  Prediction of perineural invasion and its prognostic value in patients with prostate cancer.

Authors:  Jun Taik Lee; Seungsoo Lee; Chang Jin Yun; Byung Joo Jeon; Jung Man Kim; Hong Koo Ha; Wan Lee; Moon Kee Chung
Journal:  Korean J Urol       Date:  2010-11-17

7.  Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical Prostatectomy.

Authors:  Hassan Niroomand; Mohammadreza Nowroozi; Mohsen Ayati; Hassan Jamshidian; Amir Arbab; Seyed Ali Momeni; Alireza Ghadian; Hamidreza Ghorbani
Journal:  Nephrourol Mon       Date:  2016-03-16

8.  A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago.

Authors:  Ian Hosein; Rajendra Sukhraj; Lester Goetz; Nastassia Rambarran; Satyendra Persaud
Journal:  Adv Urol       Date:  2016-07-17

Review 9.  Perineural invasion as an independent predictor of biochemical recurrence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.

Authors:  Li-Jin Zhang; Bin Wu; Zhen-Lei Zha; Wei Qu; Hu Zhao; Jun Yuan; Ye-Jun Feng
Journal:  BMC Urol       Date:  2018-02-01       Impact factor: 2.264

10.  Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies.

Authors:  Erin M Baumgartner; Kristin K Porter; Jeffrey W Nix; Soroush Rais-Bahrami; Jennifer B Gordetsky
Journal:  Transl Androl Urol       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.